Dechra Pharmaceuticals

Dechra Pharmaceuticals


Launch date
Employees
Market cap
AUD9.0b
Enterprise valuation
AUD9.9b (Public information from Jan 2024)
Company register number 03369634
Northwich England (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
GBP2020202120222023202420252026
Revenues515m608m682m762m837m904m954m
% growth7 %18 %12 %12 %10 %8 %6 %
EBITDA131m162m254m98.1m232m248m283m
% EBITDA margin25 %27 %37 %13 %28 %27 %30 %
Profit33.9m55.5m58.2m(27.9m)97.0m123m187m
% profit margin7 %9 %9 %(4 %)12 %14 %20 %
EV / revenue6.2x8.1x5.8x6.1x5.6x5.0x4.7x
EV / EBITDA24.4x30.4x15.6x47.2x20.1x18.4x15.7x
R&D budget28.4m32.4m36.1m60.8m---
R&D % of revenue6 %5 %5 %8 %---
  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO
*

£4.5b

Valuation: £4.5b

6.5x EV/LTM Revenues

17.6x EV/LTM EBITDA

Buyout
Total Funding-

Recent News about Dechra Pharmaceuticals

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Dechra Pharmaceuticals

Edit
Piedmont Animal Health
ACQUISITION by Dechra Pharmaceuticals Jul 2022
Putney
ACQUISITION by Dechra Pharmaceuticals Mar 2016
Eurovet Animal Health
ACQUISITION by Dechra Pharmaceuticals Apr 2012
Genera d.d.
ACQUISITION by Dechra Pharmaceuticals Aug 2015
DermaPet
ACQUISITION by Dechra Pharmaceuticals Oct 2010
Vencofarma
ACQUISITION by Dechra Pharmaceuticals Dec 2018
AST Farma
ACQUISITION by Dechra Pharmaceuticals Jan 2018
Apex Laboratories
ACQUISITION by Dechra Pharmaceuticals Sep 2016
Invetx
ACQUISITION by Dechra Pharmaceuticals Jul 2024